Antipodes Partners’s Stellantis STLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,089,187
Closed -$87.4M 87
2024
Q1
$87.4M Buy
3,089,187
+3,087,517
+184,881% +$76.9M 2.77% 15
2023
Q4
$38K Sell
1,670
-5,748,387
-100% -$119M ﹤0.01% 65
2023
Q3
$111M Buy
5,750,057
+156,759
+3% +$2.93M 3.56% 11
2023
Q2
$98.1M Buy
5,593,298
+27,213
+0.5% +$456K 3.39% 13
2023
Q1
$101M Buy
+5,566,085
New +$93M 3.51% 12

Other funds holding STLA

Antipodes Partners's STLA Position: Q2 2024 in Review

Antipodes Partners sold out of Stellantis (STLA) in Q2 2024, closing a stake of 3,089,187 shares — an estimated $87.4M sold.

Antipodes Partners first reported a position in STLA in Q1 2023 and held it in 5 quarters. The position peaked at $111M in Q3 2023. 463 funds tracked by Wall St. Rank hold STLA as of Q2 2024.

  • Antipodes Partners reported no remaining Stellantis position as of Q2 2024 after selling out during the quarter.
  • Antipodes Partners sold 3,089,187 Stellantis shares in Q2 2024, an estimated $87.4M.
  • Antipodes Partners first reported a position in Stellantis in Q1 2023 and held it in 5 quarters.
  • Antipodes Partners's Stellantis position peaked at $111M in Q3 2023.
  • 463 funds tracked by Wall St. Rank held Stellantis as of Q2 2024.

Based on Antipodes Partners's 13F filing for Q2 2024, filed 5 Aug 2024.